Sugar pills may effectively relieve chronic pain: Study

Image
Press Trust of India Washington
Last Updated : Sep 13 2018 | 2:40 PM IST

Sugar pills may reduce chronic pain in certain patients as effectively as any powerful drug on the market, a study claims.

Scientists at Northwestern University in the US have shown they can reliably predict which chronic pain patients will respond to a sugar placebo pill based on the patients' brain anatomy and psychological characteristics.

"Their brain is already tuned to respond," said A Vania Apkarian, a professor at Northwestern University.

"They have the appropriate psychology and biology that puts them in a cognitive state that as soon as you say, 'this may make your pain better,' their pain gets better," Apkarian said.

"You can tell them, 'I'm giving you a drug that has no physiological effect but your brain will respond to it,'" he said.

Researchers said that it is much better to give someone a non-active drug rather than an active drug and get the same result.

Most pharmacological treatments have long-term adverse effects or addictive properties. Placebo becomes as good an option for treatment as any drug we have on the market, they said.

A sugar pill prescription for chronic pain patients would result in vast cost savings for patients and the health care system, Apkarian said.

In the study published in the journal Nature Communications, about 60 chronic back pain patients were randomised into two arms of the study.

In one arm, subjects did not know if they got the drug or the placebo.

The other study arm included people who came to the clinic but did not get a placebo or drug. They were the control group.

The individuals whose pain decreased as a result of the sugar pill had a similar brain anatomy and psychological traits.

The right side of their emotional brain was larger than the left, and they had a larger cortical sensory area than people who were not responsive to the placebo, researchers said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 13 2018 | 2:40 PM IST

Next Story